IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q4 2016 Holdings

Filed 2017-02-14 | 12 holdings | $388.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$359.0K13,24192.5%
Strongbridge Biopharma PLCSHS USDG85347105$12.9K5,394,9943.3%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$12.1K2,123,5673.1%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$1.5K8,9450.4%
Garrison Cap Inc(GARSUSD)COM366554103$48752,1280.1%
CM FIN IncCOM12574Q103$39842,7570.1%
Paratek Pharmaceuticals IncCOM699374302$33821,9230.1%
Team Health Holdings IncCOM87817A107$3287,5480.1%
Adient PLC(ADNT)ORD SHSG0084W101$2784,7370.1%
American Cap SR Floating LTDCOM02504D108$21317,9310.1%
Cidara Therapeutics IncCOM171757107$21220,3580.1%
Stellus Cap Invt Corp(SCM)COM858568108$18815,5930.0%